Compared with on-demand treatment, prophylaxis with concizumab -- designed to achieve hemostasis in all hemophilia types -- reduced annualized bleeding rates among patients who have hemophilia A or B ...

Hemophilia C, also known as factor XI deficiency, is a type of bleeding disorder. It occurs due to a deficiency in factor XI, which is a protein that plays an important role in the formation of blood ...

Many people with hemophilia A can lead ordinary, active lives. Learning more about this genetic condition can support effective long-term management strategies. Hemophilia A is a genetic condition ...

Hemophilia is a rare, genetic blood condition. In fact, according to the U.S. Centers for Disease Control and Prevention (CDC), in 2022 33,000 Americans had the disorder that occurs when blood doesn’t ...

A single dose of experimental gene therapy GS001 reduced bleeding episodes in men with severe hemophilia A, a study showed.

A small survey in Germany found many men with severe hemophilia are not interested in gene therapy, which may suggest gaps in ...

The high health care burden faced by individuals with hemophilia underscores the urgent need for innovative treatments and improved diversity in clinical trials. Historically, Black, African American ...

IN the vibrant city of Dublin, Ireland, over 2,000 delegates from over 77 countries gathered for the 19th annual European ...

For many families living with haemophilia, a simple fall or minor injury can quickly become a life and death situation. The inherited bleeding disorder, which prevents the blood from clotting properly ...

For people with the bleeding disorder hemophilia, life can seem like one continuous state of alertness. If they accidentally cut their finger while chopping vegetables, they have to immediately ...

These results were consistent across hemophilia type, age, and geographies. Additionally, a median ABR of 0 (95% CI: 0.00-14.91) was observed with HYMPAVZI compared to 16.42 (95% CI: 0.00-69.10) with ...